ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Escitalopram Oxalate API Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-33G5895
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Escitalopram Oxalate API Market Insights Forecast to 2028
BUY CHAPTERS

Global Escitalopram Oxalate API Market Research Report 2025

Code: QYRE-Auto-33G5895
Report
March 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Cipla Ltd
Sichuan Kelun
Zhejiang Huahai
Haisen Pharma
Viatris
Aurobindo
Hetero Labs
Neuland
Smilax Laboratories
Jubilant Generics
Cadila Pharmaceuticals
Natco Pharma
Shodhana Laboratories
Dr. Reddy's

Escitalopram Oxalate API Market Size

The global market for Escitalopram Oxalate API was valued at US$ 73.5 million in the year 2024 and is projected to reach a revised size of US$ 117 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Escitalopram Oxalate API Market

Escitalopram Oxalate API Market

Escitalopram is used to treat depression and anxiety. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. The mechanism of antidepressant action of escitalopram, the S-enantiomer of racemic citalopram, is presumed to be linked to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).
Escitalopram oxalate is an active pharmaceutical ingredient (API) used in the manufacturing of antidepressant medications. Escitalopram oxalate API is a fine white to off-white crystalline powder, which is soluble in water and typically used in tablet form.
Global key players of Escitalopram Oxalate API include Zhejiang Huahai, Dr. Reddy"s, Shodhana Laboratories, Viatris, Aurobindo, etc. The top five players hold a share over 55%. Asia Pacific dominates the global Escitalopram Oxalate API market, with a share over 50% of the sales in value. In addition, Europe is also an important sales region. In terms of product type, both USDMF and COS/E-DMF is the largest segment, with a share about 90%. In terms of product application, the largest application is depression drug, with a share about 77%, followed by anxiety drug.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Escitalopram Oxalate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Escitalopram Oxalate API.
The Escitalopram Oxalate API market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Escitalopram Oxalate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Escitalopram Oxalate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Escitalopram Oxalate API Market Report

Report Metric Details
Report Name Escitalopram Oxalate API Market
Accounted market size in year US$ 73.5 million
Forecasted market size in 2031 US$ 117 million
CAGR 6.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Both USDMF and COS/E-DM
  • Only USDMF or COS/E-DM
Segment by Application
  • Depression Drug
  • Anxiety Drug
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sichuan Kelun, Zhejiang Huahai, Haisen Pharma, Viatris, Cipla, Aurobindo, Hetero Labs, Neuland, Smilax Laboratories, Jubilant Generics, Cadila Pharmaceuticals, Natco Pharma, Shodhana Laboratories, Dr. Reddy's
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Escitalopram Oxalate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Escitalopram Oxalate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Escitalopram Oxalate API Market growing?

Ans: The Escitalopram Oxalate API Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Escitalopram Oxalate API Market size in 2031?

Ans: The Escitalopram Oxalate API Market size in 2031 will be US$ 117 million.

What is the market share of major companies in Escitalopram Oxalate API Market?

Ans: The top five players hold a share over 55%.

What is the Escitalopram Oxalate API Market share by region?

Ans: Asia Pacific dominates the global Escitalopram Oxalate API market, with a share over 50% of the sales in value.

Who are the main players in the Escitalopram Oxalate API Market report?

Ans: The main players in the Escitalopram Oxalate API Market are Sichuan Kelun, Zhejiang Huahai, Haisen Pharma, Viatris, Cipla, Aurobindo, Hetero Labs, Neuland, Smilax Laboratories, Jubilant Generics, Cadila Pharmaceuticals, Natco Pharma, Shodhana Laboratories, Dr. Reddy's

What are the Application segmentation covered in the Escitalopram Oxalate API Market report?

Ans: The Applications covered in the Escitalopram Oxalate API Market report are Depression Drug, Anxiety Drug

What are the Type segmentation covered in the Escitalopram Oxalate API Market report?

Ans: The Types covered in the Escitalopram Oxalate API Market report are Both USDMF and COS/E-DM, Only USDMF or COS/E-DM

Recommended Reports

Antidepressants and Anxiety

API Market Reports

Other Pharmaceutical APIs

1 Escitalopram Oxalate API Market Overview
1.1 Product Definition
1.2 Escitalopram Oxalate API by Type
1.2.1 Global Escitalopram Oxalate API Market Value Comparison by Type (2024 VS 2031)
1.2.2 Both USDMF and COS/E-DM
1.2.3 Only USDMF or COS/E-DM
1.3 Escitalopram Oxalate API by Application
1.3.1 Global Escitalopram Oxalate API Market Value by Application (2024 VS 2031)
1.3.2 Depression Drug
1.3.3 Anxiety Drug
1.4 Global Escitalopram Oxalate API Market Size Estimates and Forecasts
1.4.1 Global Escitalopram Oxalate API Revenue 2020-2031
1.4.2 Global Escitalopram Oxalate API Sales 2020-2031
1.4.3 Global Escitalopram Oxalate API Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Escitalopram Oxalate API Market Competition by Manufacturers
2.1 Global Escitalopram Oxalate API Sales Market Share by Manufacturers (2020-2025)
2.2 Global Escitalopram Oxalate API Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Escitalopram Oxalate API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Escitalopram Oxalate API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Escitalopram Oxalate API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Escitalopram Oxalate API, Product Type & Application
2.7 Global Key Manufacturers of Escitalopram Oxalate API, Date of Enter into This Industry
2.8 Global Escitalopram Oxalate API Market Competitive Situation and Trends
2.8.1 Global Escitalopram Oxalate API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Escitalopram Oxalate API Players Market Share by Revenue
2.8.3 Global Escitalopram Oxalate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Escitalopram Oxalate API Market Scenario by Region
3.1 Global Escitalopram Oxalate API Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Escitalopram Oxalate API Sales by Region: 2020-2031
3.2.1 Global Escitalopram Oxalate API Sales by Region: 2020-2025
3.2.2 Global Escitalopram Oxalate API Sales by Region: 2026-2031
3.3 Global Escitalopram Oxalate API Revenue by Region: 2020-2031
3.3.1 Global Escitalopram Oxalate API Revenue by Region: 2020-2025
3.3.2 Global Escitalopram Oxalate API Revenue by Region: 2026-2031
3.4 North America Escitalopram Oxalate API Market Facts & Figures by Country
3.4.1 North America Escitalopram Oxalate API Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Escitalopram Oxalate API Sales by Country (2020-2031)
3.4.3 North America Escitalopram Oxalate API Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Escitalopram Oxalate API Market Facts & Figures by Country
3.5.1 Europe Escitalopram Oxalate API Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Escitalopram Oxalate API Sales by Country (2020-2031)
3.5.3 Europe Escitalopram Oxalate API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Escitalopram Oxalate API Market Facts & Figures by Region
3.6.1 Asia Pacific Escitalopram Oxalate API Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Escitalopram Oxalate API Sales by Region (2020-2031)
3.6.3 Asia Pacific Escitalopram Oxalate API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Escitalopram Oxalate API Market Facts & Figures by Country
3.7.1 Latin America Escitalopram Oxalate API Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Escitalopram Oxalate API Sales by Country (2020-2031)
3.7.3 Latin America Escitalopram Oxalate API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Escitalopram Oxalate API Market Facts & Figures by Country
3.8.1 Middle East and Africa Escitalopram Oxalate API Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Escitalopram Oxalate API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Escitalopram Oxalate API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Escitalopram Oxalate API Sales by Type (2020-2031)
4.1.1 Global Escitalopram Oxalate API Sales by Type (2020-2025)
4.1.2 Global Escitalopram Oxalate API Sales by Type (2026-2031)
4.1.3 Global Escitalopram Oxalate API Sales Market Share by Type (2020-2031)
4.2 Global Escitalopram Oxalate API Revenue by Type (2020-2031)
4.2.1 Global Escitalopram Oxalate API Revenue by Type (2020-2025)
4.2.2 Global Escitalopram Oxalate API Revenue by Type (2026-2031)
4.2.3 Global Escitalopram Oxalate API Revenue Market Share by Type (2020-2031)
4.3 Global Escitalopram Oxalate API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Escitalopram Oxalate API Sales by Application (2020-2031)
5.1.1 Global Escitalopram Oxalate API Sales by Application (2020-2025)
5.1.2 Global Escitalopram Oxalate API Sales by Application (2026-2031)
5.1.3 Global Escitalopram Oxalate API Sales Market Share by Application (2020-2031)
5.2 Global Escitalopram Oxalate API Revenue by Application (2020-2031)
5.2.1 Global Escitalopram Oxalate API Revenue by Application (2020-2025)
5.2.2 Global Escitalopram Oxalate API Revenue by Application (2026-2031)
5.2.3 Global Escitalopram Oxalate API Revenue Market Share by Application (2020-2031)
5.3 Global Escitalopram Oxalate API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sichuan Kelun
6.1.1 Sichuan Kelun Company Information
6.1.2 Sichuan Kelun Description and Business Overview
6.1.3 Sichuan Kelun Escitalopram Oxalate API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sichuan Kelun Escitalopram Oxalate API Product Portfolio
6.1.5 Sichuan Kelun Recent Developments/Updates
6.2 Zhejiang Huahai
6.2.1 Zhejiang Huahai Company Information
6.2.2 Zhejiang Huahai Description and Business Overview
6.2.3 Zhejiang Huahai Escitalopram Oxalate API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zhejiang Huahai Escitalopram Oxalate API Product Portfolio
6.2.5 Zhejiang Huahai Recent Developments/Updates
6.3 Haisen Pharma
6.3.1 Haisen Pharma Company Information
6.3.2 Haisen Pharma Description and Business Overview
6.3.3 Haisen Pharma Escitalopram Oxalate API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Haisen Pharma Escitalopram Oxalate API Product Portfolio
6.3.5 Haisen Pharma Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Escitalopram Oxalate API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Viatris Escitalopram Oxalate API Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Company Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Escitalopram Oxalate API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cipla Escitalopram Oxalate API Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Aurobindo
6.6.1 Aurobindo Company Information
6.6.2 Aurobindo Description and Business Overview
6.6.3 Aurobindo Escitalopram Oxalate API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Aurobindo Escitalopram Oxalate API Product Portfolio
6.6.5 Aurobindo Recent Developments/Updates
6.7 Hetero Labs
6.7.1 Hetero Labs Company Information
6.7.2 Hetero Labs Description and Business Overview
6.7.3 Hetero Labs Escitalopram Oxalate API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hetero Labs Escitalopram Oxalate API Product Portfolio
6.7.5 Hetero Labs Recent Developments/Updates
6.8 Neuland
6.8.1 Neuland Company Information
6.8.2 Neuland Description and Business Overview
6.8.3 Neuland Escitalopram Oxalate API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Neuland Escitalopram Oxalate API Product Portfolio
6.8.5 Neuland Recent Developments/Updates
6.9 Smilax Laboratories
6.9.1 Smilax Laboratories Company Information
6.9.2 Smilax Laboratories Description and Business Overview
6.9.3 Smilax Laboratories Escitalopram Oxalate API Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Smilax Laboratories Escitalopram Oxalate API Product Portfolio
6.9.5 Smilax Laboratories Recent Developments/Updates
6.10 Jubilant Generics
6.10.1 Jubilant Generics Company Information
6.10.2 Jubilant Generics Description and Business Overview
6.10.3 Jubilant Generics Escitalopram Oxalate API Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Jubilant Generics Escitalopram Oxalate API Product Portfolio
6.10.5 Jubilant Generics Recent Developments/Updates
6.11 Cadila Pharmaceuticals
6.11.1 Cadila Pharmaceuticals Company Information
6.11.2 Cadila Pharmaceuticals Description and Business Overview
6.11.3 Cadila Pharmaceuticals Escitalopram Oxalate API Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Cadila Pharmaceuticals Escitalopram Oxalate API Product Portfolio
6.11.5 Cadila Pharmaceuticals Recent Developments/Updates
6.12 Natco Pharma
6.12.1 Natco Pharma Company Information
6.12.2 Natco Pharma Description and Business Overview
6.12.3 Natco Pharma Escitalopram Oxalate API Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Natco Pharma Escitalopram Oxalate API Product Portfolio
6.12.5 Natco Pharma Recent Developments/Updates
6.13 Shodhana Laboratories
6.13.1 Shodhana Laboratories Company Information
6.13.2 Shodhana Laboratories Description and Business Overview
6.13.3 Shodhana Laboratories Escitalopram Oxalate API Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shodhana Laboratories Escitalopram Oxalate API Product Portfolio
6.13.5 Shodhana Laboratories Recent Developments/Updates
6.14 Dr. Reddy's
6.14.1 Dr. Reddy's Company Information
6.14.2 Dr. Reddy's Description and Business Overview
6.14.3 Dr. Reddy's Escitalopram Oxalate API Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Dr. Reddy's Escitalopram Oxalate API Product Portfolio
6.14.5 Dr. Reddy's Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Escitalopram Oxalate API Industry Chain Analysis
7.2 Escitalopram Oxalate API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Escitalopram Oxalate API Production Mode & Process Analysis
7.4 Escitalopram Oxalate API Sales and Marketing
7.4.1 Escitalopram Oxalate API Sales Channels
7.4.2 Escitalopram Oxalate API Distributors
7.5 Escitalopram Oxalate API Customer Analysis
8 Escitalopram Oxalate API Market Dynamics
8.1 Escitalopram Oxalate API Industry Trends
8.2 Escitalopram Oxalate API Market Drivers
8.3 Escitalopram Oxalate API Market Challenges
8.4 Escitalopram Oxalate API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Cipla Ltd
Sichuan Kelun
Zhejiang Huahai
Haisen Pharma
Viatris
Aurobindo
Hetero Labs
Neuland
Smilax Laboratories
Jubilant Generics
Cadila Pharmaceuticals
Natco Pharma
Shodhana Laboratories
Dr. Reddy's
List of Tables
 Table 1. Global Escitalopram Oxalate API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Escitalopram Oxalate API Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Escitalopram Oxalate API Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Escitalopram Oxalate API Sales (MT) of Key Manufacturers (2020-2025)
 Table 5. Global Escitalopram Oxalate API Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Escitalopram Oxalate API Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Escitalopram Oxalate API Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Escitalopram Oxalate API Average Price (US$/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Escitalopram Oxalate API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Escitalopram Oxalate API, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Escitalopram Oxalate API, Product Type & Application
 Table 12. Global Key Manufacturers of Escitalopram Oxalate API, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Escitalopram Oxalate API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Escitalopram Oxalate API as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Escitalopram Oxalate API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Escitalopram Oxalate API Sales by Region (2020-2025) & (MT)
 Table 18. Global Escitalopram Oxalate API Sales Market Share by Region (2020-2025)
 Table 19. Global Escitalopram Oxalate API Sales by Region (2026-2031) & (MT)
 Table 20. Global Escitalopram Oxalate API Sales Market Share by Region (2026-2031)
 Table 21. Global Escitalopram Oxalate API Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Escitalopram Oxalate API Revenue Market Share by Region (2020-2025)
 Table 23. Global Escitalopram Oxalate API Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Escitalopram Oxalate API Revenue Market Share by Region (2026-2031)
 Table 25. North America Escitalopram Oxalate API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Escitalopram Oxalate API Sales by Country (2020-2025) & (MT)
 Table 27. North America Escitalopram Oxalate API Sales by Country (2026-2031) & (MT)
 Table 28. North America Escitalopram Oxalate API Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Escitalopram Oxalate API Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Escitalopram Oxalate API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Escitalopram Oxalate API Sales by Country (2020-2025) & (MT)
 Table 32. Europe Escitalopram Oxalate API Sales by Country (2026-2031) & (MT)
 Table 33. Europe Escitalopram Oxalate API Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Escitalopram Oxalate API Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Escitalopram Oxalate API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Escitalopram Oxalate API Sales by Region (2020-2025) & (MT)
 Table 37. Asia Pacific Escitalopram Oxalate API Sales by Region (2026-2031) & (MT)
 Table 38. Asia Pacific Escitalopram Oxalate API Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Escitalopram Oxalate API Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Escitalopram Oxalate API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Escitalopram Oxalate API Sales by Country (2020-2025) & (MT)
 Table 42. Latin America Escitalopram Oxalate API Sales by Country (2026-2031) & (MT)
 Table 43. Latin America Escitalopram Oxalate API Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Escitalopram Oxalate API Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Escitalopram Oxalate API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Escitalopram Oxalate API Sales by Country (2020-2025) & (MT)
 Table 47. Middle East and Africa Escitalopram Oxalate API Sales by Country (2026-2031) & (MT)
 Table 48. Middle East and Africa Escitalopram Oxalate API Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Escitalopram Oxalate API Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Escitalopram Oxalate API Sales (MT) by Type (2020-2025)
 Table 51. Global Escitalopram Oxalate API Sales (MT) by Type (2026-2031)
 Table 52. Global Escitalopram Oxalate API Sales Market Share by Type (2020-2025)
 Table 53. Global Escitalopram Oxalate API Sales Market Share by Type (2026-2031)
 Table 54. Global Escitalopram Oxalate API Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Escitalopram Oxalate API Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Escitalopram Oxalate API Revenue Market Share by Type (2020-2025)
 Table 57. Global Escitalopram Oxalate API Revenue Market Share by Type (2026-2031)
 Table 58. Global Escitalopram Oxalate API Price (US$/Kg) by Type (2020-2025)
 Table 59. Global Escitalopram Oxalate API Price (US$/Kg) by Type (2026-2031)
 Table 60. Global Escitalopram Oxalate API Sales (MT) by Application (2020-2025)
 Table 61. Global Escitalopram Oxalate API Sales (MT) by Application (2026-2031)
 Table 62. Global Escitalopram Oxalate API Sales Market Share by Application (2020-2025)
 Table 63. Global Escitalopram Oxalate API Sales Market Share by Application (2026-2031)
 Table 64. Global Escitalopram Oxalate API Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Escitalopram Oxalate API Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Escitalopram Oxalate API Revenue Market Share by Application (2020-2025)
 Table 67. Global Escitalopram Oxalate API Revenue Market Share by Application (2026-2031)
 Table 68. Global Escitalopram Oxalate API Price (US$/Kg) by Application (2020-2025)
 Table 69. Global Escitalopram Oxalate API Price (US$/Kg) by Application (2026-2031)
 Table 70. Sichuan Kelun Company Information
 Table 71. Sichuan Kelun Description and Business Overview
 Table 72. Sichuan Kelun Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Sichuan Kelun Escitalopram Oxalate API Product
 Table 74. Sichuan Kelun Recent Developments/Updates
 Table 75. Zhejiang Huahai Company Information
 Table 76. Zhejiang Huahai Description and Business Overview
 Table 77. Zhejiang Huahai Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. Zhejiang Huahai Escitalopram Oxalate API Product
 Table 79. Zhejiang Huahai Recent Developments/Updates
 Table 80. Haisen Pharma Company Information
 Table 81. Haisen Pharma Description and Business Overview
 Table 82. Haisen Pharma Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Haisen Pharma Escitalopram Oxalate API Product
 Table 84. Haisen Pharma Recent Developments/Updates
 Table 85. Viatris Company Information
 Table 86. Viatris Description and Business Overview
 Table 87. Viatris Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Viatris Escitalopram Oxalate API Product
 Table 89. Viatris Recent Developments/Updates
 Table 90. Cipla Company Information
 Table 91. Cipla Description and Business Overview
 Table 92. Cipla Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. Cipla Escitalopram Oxalate API Product
 Table 94. Cipla Recent Developments/Updates
 Table 95. Aurobindo Company Information
 Table 96. Aurobindo Description and Business Overview
 Table 97. Aurobindo Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. Aurobindo Escitalopram Oxalate API Product
 Table 99. Aurobindo Recent Developments/Updates
 Table 100. Hetero Labs Company Information
 Table 101. Hetero Labs Description and Business Overview
 Table 102. Hetero Labs Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. Hetero Labs Escitalopram Oxalate API Product
 Table 104. Hetero Labs Recent Developments/Updates
 Table 105. Neuland Company Information
 Table 106. Neuland Description and Business Overview
 Table 107. Neuland Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. Neuland Escitalopram Oxalate API Product
 Table 109. Neuland Recent Developments/Updates
 Table 110. Smilax Laboratories Company Information
 Table 111. Smilax Laboratories Description and Business Overview
 Table 112. Smilax Laboratories Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 113. Smilax Laboratories Escitalopram Oxalate API Product
 Table 114. Smilax Laboratories Recent Developments/Updates
 Table 115. Jubilant Generics Company Information
 Table 116. Jubilant Generics Description and Business Overview
 Table 117. Jubilant Generics Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 118. Jubilant Generics Escitalopram Oxalate API Product
 Table 119. Jubilant Generics Recent Developments/Updates
 Table 120. Cadila Pharmaceuticals Company Information
 Table 121. Cadila Pharmaceuticals Description and Business Overview
 Table 122. Cadila Pharmaceuticals Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 123. Cadila Pharmaceuticals Escitalopram Oxalate API Product
 Table 124. Cadila Pharmaceuticals Recent Developments/Updates
 Table 125. Natco Pharma Company Information
 Table 126. Natco Pharma Description and Business Overview
 Table 127. Natco Pharma Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 128. Natco Pharma Escitalopram Oxalate API Product
 Table 129. Natco Pharma Recent Developments/Updates
 Table 130. Shodhana Laboratories Company Information
 Table 131. Shodhana Laboratories Description and Business Overview
 Table 132. Shodhana Laboratories Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 133. Shodhana Laboratories Escitalopram Oxalate API Product
 Table 134. Shodhana Laboratories Recent Developments/Updates
 Table 135. Dr. Reddy's Company Information
 Table 136. Dr. Reddy's Description and Business Overview
 Table 137. Dr. Reddy's Escitalopram Oxalate API Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 138. Dr. Reddy's Escitalopram Oxalate API Product
 Table 139. Dr. Reddy's Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Escitalopram Oxalate API Distributors List
 Table 143. Escitalopram Oxalate API Customers List
 Table 144. Escitalopram Oxalate API Market Trends
 Table 145. Escitalopram Oxalate API Market Drivers
 Table 146. Escitalopram Oxalate API Market Challenges
 Table 147. Escitalopram Oxalate API Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Escitalopram Oxalate API
 Figure 2. Global Escitalopram Oxalate API Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Escitalopram Oxalate API Market Share by Type: 2024 & 2031
 Figure 4. Both USDMF and COS/E-DM Product Picture
 Figure 5. Only USDMF or COS/E-DM Product Picture
 Figure 6. Global Escitalopram Oxalate API Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Escitalopram Oxalate API Market Share by Application: 2024 & 2031
 Figure 8. Depression Drug
 Figure 9. Anxiety Drug
 Figure 10. Global Escitalopram Oxalate API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Escitalopram Oxalate API Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Escitalopram Oxalate API Sales (2020-2031) & (MT)
 Figure 13. Global Escitalopram Oxalate API Average Price (US$/Kg) & (2020-2031)
 Figure 14. Escitalopram Oxalate API Report Years Considered
 Figure 15. Escitalopram Oxalate API Sales Share by Manufacturers in 2024
 Figure 16. Global Escitalopram Oxalate API Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Escitalopram Oxalate API Players: Market Share by Revenue in Escitalopram Oxalate API in 2024
 Figure 18. Escitalopram Oxalate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Escitalopram Oxalate API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Escitalopram Oxalate API Sales Market Share by Country (2020-2031)
 Figure 21. North America Escitalopram Oxalate API Revenue Market Share by Country (2020-2031)
 Figure 22. United States Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Escitalopram Oxalate API Sales Market Share by Country (2020-2031)
 Figure 25. Europe Escitalopram Oxalate API Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Escitalopram Oxalate API Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Escitalopram Oxalate API Revenue Market Share by Region (2020-2031)
 Figure 33. China Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Escitalopram Oxalate API Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Escitalopram Oxalate API Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Escitalopram Oxalate API Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Escitalopram Oxalate API Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Escitalopram Oxalate API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Escitalopram Oxalate API by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Escitalopram Oxalate API by Type (2020-2031)
 Figure 52. Global Escitalopram Oxalate API Price (US$/Kg) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Escitalopram Oxalate API by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Escitalopram Oxalate API by Application (2020-2031)
 Figure 55. Global Escitalopram Oxalate API Price (US$/Kg) by Application (2020-2031)
 Figure 56. Escitalopram Oxalate API Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Enalapril Market Research Report 2024
Depression Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sertraline Market Insights Forecast to 2030
Anti depressant Drugs Market
Global SNRIs Antidepressants Market Research Report 2024
Anti Depression Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Selective Serotonin Reuptake Inhibitors SSRIs Market Insights Forecast to 2030
Global Escitalopram Oxalate Market Research Report 2024
Global Citalopram Market Research Report 2024
Global Escitalopram Tablets Market Research Report 2024
Global Paroxetine Market Insights Forecast to 2030
Global Doxepin Hydrochloride Tablets Market Research Report 2024
Global Sertraline HCl Market Research Report 2024
Global NaSSAs Antidepressants Market Research Report 2024
Global Venlafaxine Hydrochloride Extended Release Capsules Market Research Report 2024
Global Mirtazapine Tablets Market Research Report 2024
Global Selective Serotonin Reuptake Inhibitor Drugs Market Research Report 2024
Global Reversible Inhibitors of Monoamine RIMA Antidepressants Market Research Report 2024
Global Venlafaxine Preparations Market Research Report 2024
Global Moclobemide Tablet Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions